Recombinant activated factor VII use in critically ill infants with active hemorrhage.


INTRODUCTION Recombinant activated factor VII (rFVIIa) is infrequently used off-label in infants despite a paucity of data in this population. We report a retrospective review of rFVIIa use in infants focusing on safety and efficacy. METHOD Between 2002 and 2007, 32 critically ill nonhemophiliac infants less than 1 year old received rFVIIa at our… (More)
DOI: 10.1016/j.jpedsurg.2008.08.053


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics